PMID
Data
Article Title
Organization
2,4,6-Triaminopyrimidine as a Novel Hinge Binder in a Series of PI3Kd Selective Inhibitors.

Gilead Sciences
Discovery of highly selective CRAF inhibitors, 3-carboxamido-2H-indazole-6-arylamide: In silico FBLD design, synthesis and evaluation.

Hanyang University
Hit-to-lead optimization of phenylsulfonyl hydrazides for a potent suppressor of PGE2 production: Synthesis, biological activity, and molecular docking study.

Kyung Hee University
Discovery of novel pyrimidine and malonamide derivatives as TGR5 agonists.

Chung-Ang University
Design, synthesis and biological evaluation of benzyl 2-(1H-imidazole-1-yl) pyrimidine analogues as selective and potent Raf inhibitors.

Hanyang University
Synthesis and PGE2 production inhibition of s-triazine derivatives as a novel scaffold in RAW 264.7 macrophage cells.

TBA
Synthesis, biological evaluation, and docking analysis of a novel family of 1-methyl-1H-pyrrole-2,5-diones as highly potent and selective cyclooxygenase-2 (COX-2) inhibitors.

Kyung Hee University
Synthesis of proline analogues as potent and selective cathepsin S inhibitors.

Hanmi Research Center
Syntheses and biological evaluation of 1-heteroaryl-2-aryl-1H-benzimidazole derivatives as c-Jun N-terminal kinase inhibitors with neuroprotective effects.

Hanyang University
Discovery of a novel series of benzimidazole derivatives as diacylglycerol acyltransferase inhibitors.

Dongguk University-Seoul
Structure based design and syntheses of amino-1H-pyrazole amide derivatives as selective Raf kinase inhibitors in melanoma cells.

Hanyang University
Syntheses of phenylpyrazolodiazepin-7-ones as conformationally rigid analogs of aminopyrazole amide scaffold and their antiproliferative effects on cancer cells.

Hanyang University
Small molecule-based reversible reprogramming of cellular lifespan.

Korea Advanced Institute of Science and Technology
Discovery of benzimidazole-indazole derivatives as potent FLT3-tyrosine kinase domain mutant kinase inhibitors for acute myeloid leukemia.

Gwangju Institute of Science and Technology (GIST)
Discovery of antiviral SARS-CoV-2 main protease inhibitors by structure-guided hit-to-lead optimization of carmofur.

Gwangju Institute of Science and Technology
Structure-Activity Relationship of Truncated 4'-Selenonucleosides: A3 Adenosine Receptor Activity and Binding Selectivity.

Seoul National University
Design, synthesis, and biological evaluation of HDAC6 inhibitors targeting L1 loop and serine 531 residue.

Keimyung University
Structural Modification and Biological Evaluation of 2,8-Disubstituted Adenine and Its Nucleosides as A2A Adenosine Receptor Antagonists: Exploring the Roles of Ribose at Adenosine Receptors.

Seoul National University
Design, Synthesis, and Biological Evaluation of New 2,6,7-Substituted Purine Derivatives as Toll-like Receptor 7 Agonists for Intranasal Vaccine Adjuvants.

Gwangju Institute of Science and Technology
Structure-Activity Relationships of Truncated 1'-Homologated Carbaadenosine Derivatives as New PPARγ/δ Ligands: A Study on Sugar Puckering Affecting Binding to PPARs.

Seoul National University
Recent advances of phenotypic screening strategies in the application of anti-influenza virus drug discovery.

Shandong University
Identification and Characterization of a Novel Indoleamine 2,3-Dioxygenase 1 Protein Degrader for Glioblastoma.

Northwestern University Feinberg School of Medicine
Design, synthesis, and biological evalution of bifunctional inhibitors against Hsp90-HDAC6 interplay.

Keimyung University
Synthesis and Evaluation of Novel Tetrahydronaphthyridine CXCR4 Antagonists with Improved Drug-like Profiles.

Emory University
Repositioning Food and Drug Administration-Approved Drugs for Inhibiting Biliverdin IXβ Reductase B as a Novel Thrombocytopenia Therapeutic Target.

Korea Basic Science Institute
A Novel, Selective c-Abl Inhibitor, Compound 5, Prevents Neurodegeneration in Parkinson's Disease.

Johns Hopkins University School of Medicine
Discovery of N-amido-phenylsulfonamide derivatives as novel microsomal prostaglandin E

Kyung Hee University
Discovery of Orally Efficacious Phosphoinositide 3-Kinase δ Inhibitors with Improved Metabolic Stability.

Gilead Sciences
SAR study of bisamides as cyclophilin a inhibitors for the development of host-targeting therapy for hepatitis C virus infection.

Chonnam National University
Sulfamoylbenzamide-based Capsid Assembly Modulators for Selective Inhibition of Hepatitis B Viral Replication.

Korea Research Institute of Chemical Technology
Design, synthesis and biological evaluation of new bivalent quinazoline analogues as IAP antagonists.

Chung-Ang University
Peripheral Selective Oxadiazolylphenyl Alanine Derivatives as Tryptophan Hydroxylase 1 Inhibitors for Obesity and Fatty Liver Disease.

Gwangju Institute of Science and Technology
Development of a Polo-like Kinase-1 Polo-Box Domain Inhibitor as a Tumor Growth Suppressor in Mice Models.

Korea Basic Science Institute (Kbsi)
Molecular design, synthesis, and biological evaluation of bisamide derivatives as cyclophilin A inhibitors for HCV treatment.

Chonnam National University
Structure activity relationship exploration of 5-hydroxy-2-(3-phenylpropyl)chromones as a unique 5-HT

Kalamazoo College
Elucidation of Mechanism for Ligand Efficacy at Leukotriene B

Incerebro
Synthesis and cytotoxic effects of 2-thio-3,4-dihydroquinazoline derivatives as novel T-type calcium channel blockers.

Kyung Hee University
Design, Synthesis, and Biological Evaluation of New Peripheral 5HT

Gwangju Institute of Science and Technology
Identification of new aryl hydrocarbon receptor (AhR) antagonists using a zebrafish model.

Gwangju Institute of Science and Technology
Discovery of Nonpungent Transient Receptor Potential Vanilloid 1 (TRPV1) Agonist as Strong Topical Analgesic.

Seoul National University
Synthesis and Structure-Activity Relationships of Arylsulfonamides as AIMP2-DX2 Inhibitors for the Development of a Novel Anticancer Therapy.

Dongguk University-Seoul
Synthesis and biological evaluation of acylthiourea against DUSP1 inhibition.

Anticancer Agent Research Center
Discovery of Novel Pyruvate Dehydrogenase Kinase 4 Inhibitors for Potential Oral Treatment of Metabolic Diseases.

Gwangju Institute of Science and Technology
Structure-Based Discovery of Novel Cyclophilin A Inhibitors for the Treatment of Hepatitis C Virus Infections.

Chonnam National University
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.

Qbi Covid-19 Research Group (Qcrg)
Identification of quinone analogues as potential inhibitors of picornavirus 3C protease in vitro.

Korea Research Institute of Chemical Technology
Discovery of novel 4-aryl-thieno[1,4]diazepin-2-one derivatives targeting multiple protein kinases as anticancer agents.

Hanyang University
Synthesis and structure-activity relationships of quinolinone and quinoline-based P2X7 receptor antagonists and their anti-sphere formation activities in glioblastoma cells.

Gwangju Institute of Science and Technology (Gist)
Methyl 3-(3-(4-(2,4,4-Trimethylpentan-2-yl)phenoxy)-propanamido)benzoate as a Novel and Dual Malate Dehydrogenase (MDH) 1/2 Inhibitor Targeting Cancer Metabolism.

Dongguk University
Inhibitors of histone deacetylase useful for the treatment or prevention of HIV infection

Merck Sharp & Dohme
Indanes as PD-L1 inhibitors

Chemocentryx
MEK INHIBITORS AND USES THEREOF

Ikena Oncology
NOVEL SPIROPYRROLIDINE DERIVED ANTIVIRAL AGENTS

Enanta Pharmaceuticals
Compounds and compositions for treating conditions associated with NLRP activity

Novartis
MCT4 inhibitors for treating disease

Vettore
Therapeutic compounds and compositions

Exithera Pharmaceuticals
MCL-1 inhibitors

Gilead Sciences
Pyrido[3,2-d]pyrimidine compounds as immunomodulators

Incyte
N-aryl oxamic acids

Purdue Research Foundation
Inhibitors of cyclin-dependent kinases

Dana-Farber Cancer Institute
Monosaccharide amine and 3-nitro-2-phenyl-2H-chromene based inhibitors of glucose kinases

University of South Carolina
Indolinones compounds and their use in the treatment of fibrotic diseases

Respivert
Benzimidazole-proline derivatives

Idorsia Pharmaceuticals
2,6-disubstituted pyridine derivative

Sumitomo Dainippon Pharma
1,3,4-thiadiazole compounds and their use in treating cancer

Cancer Research Technology
JAK1 selective inhibitors

Astrazeneca
Spirocyclic compounds

Recurium Ip Holdings
Substituted piperidine compounds

Epizyme
Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors

Incyte
Thrombin inhibitors

Merck Sharp & Dohme
Substituted quinolines as bruton's tyrosine kinases inhibitors

Hangzhouderenyucheng Biotechnology
Spectroscopic and Computational Investigations of Ligand Binding to IspH: Discovery of Non-diphosphate Inhibitors.

University of Illinois
An Allosteric Inhibitor Scaffold Targeting the PIF-Pocket of Atypical Protein Kinase C Isoforms.

Universitätsklinikum Frankfurt
Pharmaceutical compounds

Astex Therapeutics
Bivalent ligands for the treatment of neurological disorders

Virginia Commonwealth University
Thiophenecarboxamide derivatives as EP4 receptor ligands

Merck Frosst Canada
Substituted 3-arylsulfonyl-pyrazolo[1,5-A]pyrimidines, serotonin 5-HT6 receptor antagonists and methods for the production and use thereof

TBA
Targeting Tumour Proliferation with a Small-Molecule Inhibitor of AICAR Transformylase Homodimerization.

University of Southampton
Kinetics Studies on the Inhibition Mechanism of Pancreatic α-Amylase by Glycoconjugated 1H-1,2,3-Triazoles: A New Class of Inhibitors with Hypoglycemiant Activity.

Yonsei University
A novel hepatointestinal leukotriene B4 receptor. Cloning and functional characterization.

Schering-Plough Research Institute
Inactivation of a novel neuropeptide Y/peptide YY receptor gene in primate species.

Yamanouchi Pharmaceutical
Neurochemical and autonomic pharmacological profiles of the 6-aza-analogue of mianserin, Org 3770 and its enantiomers.

Organon International
Affinity reagents that target a specific inactive form of protein kinases.

University of Washington